MarginsXMarginsX
Home › Markets › Health Care › MMM

3M Company (MMM)

MMM trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$181.68
-1.08% on the day
Market cap
$93.9B
Large cap
Revenue · 2025
$24.9B
+1.5% on 2024
Net income · 2025
$3.3B
13.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/66740/000006674026000014/0000066740-26-000014-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerMMM on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000066740
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$24.9B
Net income$3.3B
Operating income$4.6B
Net margin13.0%
Operating margin18.6%
Revenue growth+1.5%
Cash$5.2B
Total assets$37.7B
P/E (computed)28.9×
P/S (computed)3.8×

Warning signs

Cash runway
Cash-flow positive
$4.8B cash at September 30, 2026
Share count, 1 year
-2.7%
2025-09-30 to 2026-09-30 · -21.8% over 3 years
Going-concern doubt
No
10-Q filed October 20, 2026
Insider net buying, 12 months
-$21.0M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-20
Cash and burn$4.8B cash; operating cash flow $907.3M a quarter.Report 2026-09-30
Shares outstanding516,729,574 (2026-09-30); 531,225,048 a year earlier; 552,317,038 three years earlier. 3y figure adjusted for splits (1.196-for-1 overall).Cover page 2026-09-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 1 424B5 takedownsLatest 2026-09-03
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2026-11-09
AuditorPricewaterhouseCoopers LLP, Minneapolis, Minnesota, United StatesPCAOB Form AP 2026-02-18
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $21.0M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$6.6B$1.4B$486.0M$4.8B$15.0B$25.2B10-Q 2026-10-20
Q2 2026
2026-06-30
$6.5B$933.0M$986.0M$3.0B$12.6B$25.2B10-Q 2026-07-21
Q1 2026
2026-03-31
$6.0B$653.0M$574.0M$3.7B$12.6B$25.0B10-Q 2026-04-21
Q4 2025
2025-12-31
$6.1B$577.0M$1.6B$5.2B$12.6B$24.9B10-K 2026-02-03
Q3 2025
2025-09-30
$6.5B$834.0M$1.8B$4.7B$12.6B$24.8B10-Q 2026-10-20
Q2 2025
2025-06-30
$6.3B$723.0M-$954.0M$3.7B$13.1B$24.6B10-Q 2026-07-21
Q1 2025
2025-03-31
$6.0B$1.1B-$79.0M$6.3B$13.5B$24.5B10-Q 2026-04-21
Q4 2024
2024-12-31
$6.0B$728.0M$1.8B$5.6B$13.0B$24.6B10-K 2025-02-05

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B22026-09-04
Latest annual report10-K2026-02-03
Latest quarterly / interim10-Q2026-10-20
Latest current report8-K2026-11-04
Latest proxyDEFA14A2026-03-27

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-0.8%
1 month+12.8%
3 months+0.6%
Year to date+14.7%
1 year+7.6%
From 52-week high-5.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
SYKStryker Corporation$310.72+0.35%$118.3B
BSXBoston Scientific Corporation$43.69-1.47%$63.3B
BDXBecton Dickinson and Company$216.47-0.72%$59.0B
MDLNMedline Inc.$39.17-0.76%$51.5B
RMDResMed Inc.$238.19-0.56%$33.5B
DXCMDexCom Inc.$81.61-2.06%$30.4B
WSTWest Pharmaceutical Services Inc.$417.80+0.33%$29.1B
SOLVSolventum Corporation$88.65-0.48%$15.0B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier